GEHC250103P82000
- 1.65
- 0.000.00%
GEヘルスケア・テクノロジーズのニュース一覧
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 55% Above Its Share Price
EvercoreはGEヘルスケア・テクノロジーズ(GEHC.US)のレーティングを強気に据え置き、目標株価を98ドルに引き下げた
EvercoreのアナリストVijay Kumarは$GE HealthCare Technologies(GEHC.US)$のレーティングを強気に据え置き、目標株価を102ドルから98ドルに引き下げた。TipRanksのデータによると、このアナリストの最近1年間の的中率は50.9%、平均リターンは3.6%である。注 TipRanksは、金融アナリストの分析データと、アナリストの的中率および平均リ
With 81% Ownership of the Shares, GE HealthCare Technologies Inc. (NASDAQ:GEHC) Is Heavily Dominated by Institutional Owners
(GEHC) - Analyzing GE HealthCare Techs's Short Interest
Why GE HealthCare Technologies (GEHC) Is a Top Value Stock for the Long-Term
Is GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) ROE Of 20% Impressive?
GE Made Spinoffs Cool Again. FedEx Is Joining the Club.
Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete
GE Healthcare Technologies Inc. (GEHC) Among Billionaire Daniel Sundheim's Stock Picks Heading Into 2025
Possible Bearish Signals With GE HealthCare Technologies Insiders Disposing Stock
Goldman Sachs Adjusts Price Target on GE Healthcare Technologies to $83 From $88, Maintains Neutral Rating
Press Release: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025
GE HealthCare Technologies To Present At Nasdaq Investor Conference; Webcast At 6:00 AM ET
Key Deals This Week: Shell-Equinor U.K. Combination, Hershey, TotalEnergies, GE HealthCare and More
ウェルズ・ファーゴはGEヘルスケア・テクノロジーズ(GEHC.US)のレーティングを強気に据え置き、目標株価を96ドルに据え置いた
ウェルズ・ファーゴのアナリストLarry Biegelsenは$GE HealthCare Technologies(GEHC.US)$のレーティングを強気に据え置き、目標株価を96ドルに据え置いた。TipRanksのデータによると、このアナリストの最近1年間の的中率は61.8%、平均リターンは12.5%である。注 TipRanksは、金融アナリストの分析データと、アナリストの的中率および平均リタ
GEHC Stock May Gain Following the Launches of Aurora and Clarify DL
GE Healthcare Unveiled 3 New Advanced Deep Learning Image Processing And Reconstruction Solutions As A Part Of Its Effortless Recon DL Portfolio At The Radiological Society Of North America 2024 Annual Meeting
GEHC Stock May Gain From Potential FDA Clearance for CleaRecon DL
The Intersection of AI, Medicine, and Stocks: A New Era of Opportunities Issued on Behalf of Avant Technologies Inc.